252 related articles for article (PubMed ID: 31124539)
21. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease.
Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA
Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A
Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
[TBL] [Abstract][Full Text] [Related]
23. Tomographic assessment of therapeutic response to uveitic macular oedema.
Sivaprasad S; Ikeji F; Xing W; Lightman S
Clin Exp Ophthalmol; 2007 Nov; 35(8):719-23. PubMed ID: 17997774
[TBL] [Abstract][Full Text] [Related]
24. The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.
Petrushkin H; Rogers D; Pavesio C
Ocul Immunol Inflamm; 2018; 26(5):795-797. PubMed ID: 28080174
[TBL] [Abstract][Full Text] [Related]
25. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study.
Berasategui B; Fonollosa A; Artaraz J; Ruiz-Arruza I; Ríos J; Matas J; Llorenç V; Diaz-Valle D; Sastre-Ibañez M; Arriola-Villalobos P; Adan A
BMC Ophthalmol; 2018 Jul; 18(1):179. PubMed ID: 30029623
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab for treatment of uveitic macular edema.
Cordero Coma M; Sobrin L; Onal S; Christen W; Foster CS
Ophthalmology; 2007 Aug; 114(8):1574-1579.e1. PubMed ID: 17363060
[TBL] [Abstract][Full Text] [Related]
27. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
Brar M; Yuson R; Kozak I; Mojana F; Cheng L; Bartsch DU; Oster SF; Freeman WR
Retina; 2010 Mar; 30(3):383-9. PubMed ID: 20216291
[TBL] [Abstract][Full Text] [Related]
28. Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis.
Iannetti L; Accorinti M; Liverani M; Caggiano C; Abdulaziz R; Pivetti-Pezzi P
Ocul Immunol Inflamm; 2008; 16(4):155-60. PubMed ID: 18716950
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.
Mackensen F; Heinz C; Becker MD; Heiligenhaus A
Retina; 2008 Jan; 28(1):41-5. PubMed ID: 18185136
[TBL] [Abstract][Full Text] [Related]
30. RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE.
Pepple KL; Nguyen MH; Pakzad-Vaezi K; Williamson K; Odell N; Lee C; Leveque TK; Van Gelder RN
Retina; 2019 May; 39(5):948-955. PubMed ID: 29346240
[TBL] [Abstract][Full Text] [Related]
31. Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.
Nomi N; Ota M; Fukumura M; Nuno Y; Hatano M; Wakuta M; Yanai R; Kimura K
Jpn J Ophthalmol; 2018 Mar; 62(2):163-167. PubMed ID: 29270811
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Macular Edema in Uveitis.
Accorinti M; Okada AA; Smith JR; Gilardi M
Ocul Immunol Inflamm; 2019; 27(2):169-180. PubMed ID: 30821631
[TBL] [Abstract][Full Text] [Related]
34. Fluocinolone acetonide intravitreal implant (Retisert
Leinonen S; Immonen I; Kotaniemi K
Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
[TBL] [Abstract][Full Text] [Related]
35. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.
Finn AP; Thomas AS; Stinnett SS; Keenan RT; Grewal DS; Jaffe GJ
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1867-1873. PubMed ID: 30128606
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.
Cervantes-Castañeda RA; Giuliari GP; Gallagher MJ; Yilmaz T; MacDonell RE; Quinones K; Foster CS
Eur J Ophthalmol; 2009; 19(4):622-9. PubMed ID: 19551679
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin for Uveitic Cystoid Macular Edema (CME).
Papadaki T; Zacharopoulos I; Iaccheri B; Fiore T; Foster CS
Ocul Immunol Inflamm; 2005 Dec; 13(6):469-70. PubMed ID: 16321893
[TBL] [Abstract][Full Text] [Related]
38. Ranibizumab for refractory uveitis-related macular edema.
Acharya NR; Hong KC; Lee SM
Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988
[TBL] [Abstract][Full Text] [Related]
39. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.
Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM
Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165
[TBL] [Abstract][Full Text] [Related]
40. Optical coherence tomography-guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes.
Reddy AK; Cabrera M; Yeh S; Davis JL; Albini TA
Retina; 2014 Dec; 34(12):2431-8. PubMed ID: 25170857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
